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The Cyclin-Dependent Kinase 5 Activators p35 and p39 Interact
with the -Subunit of Ca2/Calmodulin-Dependent Protein Kinase II
and -Actinin-1 in a Calcium-Dependent Manner
Rani Dhavan,1* Paul L. Greer,1* Maria A. Morabito,1 Lianna R. Orlando,2 and Li-Huei Tsai1,3
1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, 2Department of Neurology,
Massachusetts General Hospital, Boston, Massachusetts 02114, and 3Howard Hughes Medical Institute, Boston,
Massachusetts 02115
Cyclin-dependent kinase 5 (Cdk5) is a critical regulator of neu-
ronal migration in the developing CNS, and recent studies have
revealed a role for Cdk5 in synaptogenesis and regulation of
synaptic transmission. Deregulation of Cdk5 has been linked to
the pathology of neurodegenerative diseases such as Alzhei-
mer’s disease. Activation of Cdk5 requires its association with
a regulatory subunit, and two Cdk5 activators, p35 and p39,
have been identified. To gain further insight into the functions of
Cdk5, we identified proteins that interact with p39 in a yeast
two-hybrid screen. In this study we report that -actinin-1 and
the -subunit of Ca2/calmodulin-dependent protein kinase II
(CaMKII), two proteins localized at the postsynaptic density,
interact with Cdk5 via their association with p35 and p39.
CaMKII and -actinin-1 bind to distinct regions of p35 and
p39 and also can interact with each other. The association of
CaMKII and -actinin-1 to the Cdk5 activators, as well as to
each other, is stimulated by calcium. Further, the activation of
glutamate receptors increases the association of p35 and p39
with CaMKII, and the inhibition of CaMKII activation dimin-
ishes this effect. The glutamate-mediated increase in associa-
tion of p35 and CaMKII is mediated in large part by NMDA
receptors, suggesting that cross talk between the Cdk5 and
CaMKII signal transduction pathways may be a component of
the complex molecular mechanisms contributing to synaptic
plasticity, memory, and learning.
Key words: Cdk5; p35; p39; CaMKII; actinin; synapses; cal-
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Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/
threonine kinase that has emerged as a crucial regulator of
neuronal migration in the developing brain (Dhavan and Tsai,
2001). Cdk5-deficient mice die at birth and display widespread
disruptions in neuronal layering of many brain structures, indi-
cating impairment in directing neuronal positioning (Ohshima et
al., 1996). Activation of Cdk5 requires binding to one of two
regulatory subunits, p35 or p39 (Lew et al., 1994; Tsai et al., 1994;
Tang et al., 1995). The phenotype of the p35/p39 double knock-
out mice is identical to the Cdk5-deficient mice, suggesting that
together the two activators of Cdk5 are necessary and sufficient
for Cdk5 function (Ko et al., 2001). Over 20 functionally diverse
proteins involved in cytoskeleton dynamics, cell adhesion, trans-
port, and membrane trafficking have been identified as Cdk5
substrates, elucidating the molecular mechanisms of Cdk5 func-
tion (Dhavan and Tsai, 2001; Smith et al., 2001).
Recently, synaptic functions of Cdk5 have come to light. Cdk5
and its activators are localized at synapses and are present in
presynaptic and postsynaptic subcellular fractions, including
postsynaptic density (PSD) fractions (Humbert et al., 2000b;
Niethammer et al., 2000). Cdk5 and p35 also are enriched at the
neuromuscular junction, where Cdk5 activity is required for the
neuregulin-induced transcription of acetylcholine receptors (Fu
et al., 2001). Cdk5-mediated phosphorylation of Synapsin 1,
Munc18, Amphiphysin 1, and the -subunit (1A) of P/Q-type
voltage-dependent calcium (Ca2) channels has revealed a role
for this kinase in synaptic vesicle trafficking and neurotransmitter
release (Dhavan and Tsai, 2001; Tomizawa et al., 2002). Cdk5
also appears to play a role in postsynaptic transmission, and
phosphorylation of DARPP32 by Cdk5 modulates dopamine
signaling in striatal neurons (Bibb et al., 1999). Stimulation of
metabotropic glutamate receptors (mGluRs) in neostriatal slices
causes a transient increase in Cdk5 activity, and Cdk5 activity has
been implicated in the mGluR-mediated enhancement of voltage-
dependent Ca2 currents (Liu et al., 2001). Finally, Cdk5 phos-
phorylates the NR2A subunit of the NMDA receptor, and phar-
macological inhibition of Cdk5 modulates NMDA receptor
conductance (Li et al., 2001).
To gain further insight into the functions of Cdk5, we identi-
fied proteins that interact with its activator p39 in a yeast two-
hybrid screen. Two of the proteins identified in this screen,
-actinin-1 and Ca2/calmodulin-dependent protein kinase II
(CaMKII), are enriched at the PSD and interact with the
NMDA receptor (Wyszynski et al., 1997; Walikonis et al., 2000;
Lisman et al., 2002). We report that -actinin-1 and CaMKII
interact with p35, p39, Cdk5, and each other in a Ca2-
dependent manner. Furthermore, the activation of glutamate
receptors increases the association of p35 and p39 with
CaMKII, suggesting that synaptic activity may influence the
cross talk between Cdk5 and CaMKII.
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MATERIALS AND METHODS
Constructs. Mouse p39 cDNA was amplified by PCR, and the fragment
was inserted into the SalI and NotI sites of the pPC97 vector (pDBLeu;
Invitrogen, Carlsbad, CA) for expression as a GAL4 DNA binding
domain fusion protein (p39-pPC97). Identical cloning strategy was used
to generate p35-pPC97, p25-pPC97 (residues 99–307 of human p35),
p29-pPC97 (residues 115–367 of mouse p39), p10-pPC97 (residues 1–98
of human p35), and p19-pPC97 (residues 1–113 of mouse p39).
The cDNAs encoding the N-terminal (residues 1–316) and C-terminal
(residues 314–478) domains of CaMKII were generated by PCR from
a CaMKII-containing plasmid (a gift from Dr. H. Schulman, Stanford
University, CA) and subcloned into the SalI and NotI sites of pPC97 and
pPC86 vectors (Invitrogen) for expression as GAL4 DNA binding or
activation domain fusion proteins, respectively. A cDNA encoding full-
length -actinin-1 (I.M.A.G.E. Consortium) was used as a template to
generate truncation mutants of -actinin-1 by PCR (residues are indi-
cated in Fig. 1) and cloned into the SalI and NotI sites of pPC97 and
pPC86 vectors. The cDNAs encoding p39, p29, p35, p25, Cdk5, and the
-actinin-1 cDNA clone identified in the screen were subcloned into the
SalI and NotI sites of PGEX4T2 (Amersham Pharmacia, Uppsala, Swe-
den) for the expression of GST fusion proteins.
Yeast two-hybrid screen. A yeast two-hybrid screen was performed in
yeast strain MaV203 containing HIS3, LacZ, and URA reporter genes
under the control of the GAL4-activating sequences as described previ-
ously (Vidal et al., 1996a,b; Niethammer and Sheng, 1998). Briefly, 10
million cotransformants of p39-pPC97 and a human fetal (third trimes-
ter) brain cDNA library (Invitrogen) were screened for interacting pro-
teins by growth on synthetic dropout Leu Trp His plates containing
20 mM 3-amino-1,2,4-triazole. Positive colonies were tested further for
expression of the LacZ reporter gene by -galactosidase assay (Clontech
yeast protocol handbook, Palo Alto, CA) and for induction of the URA
reporter gene that allowed growth on Leu Trp Ura plates and
conferred sensitivity to 5-fluoroorotic acid (Vidal et al., 1996a,b). Plas-
mids were isolated from positive yeast colonies as described previously
(Niethammer and Sheng, 1998), and the interacting proteins were iden-
tified by sequencing. The p35 yeast two-hybrid screen has been described
previously (Kwon et al., 2000).
Mapping domains of interaction. pPC86--actinin-1 or pPC86-
CaMKII identified in the screen was cotransformed into MaV203 yeast
strain with pPC97-p39, p35-pPC97, p29-pPC97, p25-pPC97, p19-pPC97,
or p10-pPC97. -Galactosidase assay was used to compare the strength of
interaction among the proteins encoded by cotransformed cDNA. We
judged colonies that turned blue within 1 hr to contain strongly interact-
ing proteins (). The , , and  symbols were used to
designate colonies that turned blue within 1–4 hr, 4–8 hr, and 8–24 hr,
respectively. The  symbol was used to indicate colonies that did not
turn blue within 24 hr. To map the binding region of CaMKII, we
cotransformed the CaMKII truncation mutants in pPC86 vector with
p39-pPC97, p35-pPC97, or -actinin-1-pPC97. Deletion constructs of
-actinin-1 in pPC86 vector were cotransformed with p39-pPC97, p35-
pPC97, or CaMKII-pPC97 and were assayed as described above.
GST pulldown assay. GST fusion proteins were expressed, purified, and
cross-linked to glutathione-Sepharose 4B (Amersham Pharmacia) as
described previously (Tarricone et al., 2001). Adult rat brain was lysed in
RIPA buffer (150 mM NaCl, 50 mM Tris, pH 8.0, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS) with protease and phosphatase inhibitors [con-
taining (in mM) 1 PMSF, 1 DTT, 1 Na3VO4, 5 NaF, 2 sodium pyrophos-
phate, and 50 -glycerophosphate plus 1 g/ml aprotinin, 10 g/ml
leupeptin, and 1 nM okadaic acid] in a homogenizing Dounce and then
was spun at 13,000 rpm for 15 min at 4°C. Two milligrams of lysate were
incubated with 5 g of cross-linked GST fusion proteins in RIPA buffer
for 2 hr at 4°C. The beads were washed three times with RIPA buffer, and
the associated proteins were resolved by SDS-PAGE and analyzed by
immunoblotting.
Antibodies for immunoblotting. For Western blot analysis we used an
affinity-purified p35 polyclonal antibody (1:1000) (Ko et al., 2001), an
affinity-purified p39 polyclonal antibody (1:1000) (Humbert et al.,
2000a), a monoclonal Cdk5 antibody DC-17 (1:10) (Tsai et al., 1993), a
monoclonal CaMKII antibody (1:2000; Chemicon, Temecula, CA), a
monoclonal -actinin-1 antibody (1:1000; Sigma-Aldrich, St. Louis,
MO), an affinity-purified polyclonal Lis1 antibody (1:1000) (Smith et al.,
2000), or a polyclonal actin antibody (1:1000; Sigma-Aldrich).
Coimmunoprecipitation. Two milligrams of adult rat brain lysate (de-
scribed above) were incubated with 1 g of p35, p39, Cdk5 (C8; Santa
Cruz Biotechnology, Santa Cruz, CA), or HA (Santa Cruz Biotechnol-
ogy) polyclonal antibodies or -actinin-1 or HA (Santa Cruz Biotechnol-
ogy) monoclonal antibodies for 1 hr at 4°C in RIPA buffer. Then 100 l
of a 10% slurry of protein A-Sepharose (Amersham Pharmacia), or
IgM-Sepharose (Sigma-Aldrich) for -actinin-1 IPs, was added for 1 hr
at 4°C. The beads were washed three times with RIPA buffer, and bound
proteins were analyzed by SDS-PAGE and Western blotting. In some
cases the indicated concentration of CaCl2, MgCl2, EDTA, or EGTA
was added to adult rat brain lysate and incubated for 20 min before
coimmunoprecipitation.
Immunostaining. Dissociated hippocampal neurons from embryonic
day 18 (E18) rat brains were plated on coverslips coated with poly-L-
lysine (Sigma-Aldrich) at a density of 5  10 4/coverslips and maintained
in culture in Neurobasal medium (Invitrogen) supplemented with B27
(Invitrogen) and L-glutamine (Sigma-Aldrich) as described previously
(Brewer et al., 1993) for 3 weeks. Neurons were fixed in 4% paraformal-
dehyde/5% sucrose in PBS for 30 min at room temperature (RT),
followed by 5 min in cold methanol at –20°C. Cells were permeabilized
in blocking buffer [10% normal goat serum (NGS), 0.2% Triton X-100 in
PBS] for 1 hr at RT. Primary antibodies in staining buffer (3% NGS,
0.1% Triton X-100 in PBS) were applied for 16 hr at 4°C. The CaMKII,
p35, p39, Cdk5 (C8; Santa Cruz Biotechnology), and -actinin-1 anti-
bodies described above were used at a dilution of 1:250 for immunostain-
ing. Oregon green-conjugated anti-rabbit and Texas Red-conjugated
anti-mouse secondary antibodies (Molecular Probes, Eugene, OR) were
used at a dilution of 1:500 in staining buffer for 1 hr at RT. For triple
staining, a Texas Red-conjugated IgM-specific anti-mouse secondary
antibody was used with Oregon green-conjugated anti-rabbit and Cy5-
conjugated IgG-specific anti-mouse secondary antibodies (Molecular
Probes) to visualize -actinin-1, p35 (or p39 or Cdk5), and CaMKII,
respectively. All images were acquired by using a 60 or 100 oil-
immersion objective on a Nikon inverted microscope linked to a Delta
vision deconvolution imaging system (Applied Precision, Issaquah, WA).
Images of double- and triple-labeled cells were combined and colorized
with Adobe Photoshop software.
Glutamate treatment of hippocampal neurons. As described above, 3 
10 6 hippocampal neurons were plated on poly-L-lysine-coated 10 cm
plates. After 2 weeks in culture the medium was replaced with KRH
buffer [containing (in mM) 128 NaCl, 5 KCl, 1 NaH2PO4, 2.7 CaCl2, 1.2
MgSO4, 10 glucose, and 20 HEPES, pH 7.4] for 30 min at 37°C. Neurons
were treated with 100 M glutamate/10 M glycine in Mg 2-free KRH
buffer for 5 min and then were Dounce homogenized in ice-cold sucrose
buffer [0.32 M sucrose plus (in mM) 4 HEPES, pH 7.4, 1 MgCl2, 1
NaHCO3, and 0.5 CaCl2] containing all of the protease and phosphatase
inhibitors listed above. The homogenized cells were centrifuged at
1000 g for 10 min. The resulting supernatant was centrifuged at 3000
g for 15 min. The pellet was lysed in RIPA buffer (described above) by 10
strokes in a glass-glass Dounce homogenizer and centrifuged at 13,000
rpm for 15 min at 4°C; then the supernatant was collected. One milligram
of protein was used per immunoprecipitation, as described above.
Treatment of hippocampal slices. Hippocampal slices were prepared
from 3-week-old Sprague Dawley rats with a McIlwain tissue chopper
and placed in KRH buffer aerated with 95% O2/5% CO2. After equili-
bration at 37°C for 30 min the slices were stimulated in Mg 2-free KRH
buffer for 5 min with 100 M glutamate/10 M glycine, 100 M NMDA/10
M glycine, or 100 M AMPA. In some cases the slices were pretreated
with 10 M each KN-62, KN-93, KN-92, and MK801, 1 M H-89, 100 M
CNQX, 100 M AIDA, or 5 mM EDTA for 10 min before the stimula-
tions. Treatments were stopped on ice, and the drug was removed. Slices
were homogenized in ice-cold sucrose buffer. Lysates were prepared and
immunoprecipitations were performed as described above.
Cdk5 kinase activity. One milligram of neuronal lysate was immuno-
precipitated with p35 antibody as described above. The Sepharose-bound
complexes were washed two times with kinase buffer (20 mM MOPS, pH
7.2, 5 mM MgCl2). Kinase buffer (30 l) containing 500 M Histone H1
peptide (PKTPAKAKKL), 100 M ATP, and 5 Ci [- 32P]ATP was
incubated with the immunocomplexes for 30 min at RT. Samples were
centrifuged at 13,000 rpm for 2 min, and 10 l of the supernatant was
spotted on phosphocellulose disc paper. The discs were washed four
times with 0.3% phosphoric acid and counted in 10 ml of scintillation
fluid.
CaMKII activity f rom hippocampal slices. CaMKII-dependent activity
was measured by using a Ca 2/calmodulin-dependent protein kinase
assay system (Invitrogen) according to the manufacturer’s instructions.
Briefly, slices were Dounce homogenized in cold extraction buffer [con-
taining (in mM) 20 PIPES, pH 7.0, 0.5 EGTA, 1 EDTA, 10 sodium
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pyrophosphate, 2 DTT, and 0.4 ammonium molydate plus 10 g/ml
leupeptin and 0.1% Triton X-100]. Then 20 l of the extract was
incubated in a buffer containing (in mM) 50 PIPES, pH 7.0, 20 MgCl2,
0.05 ATP, and 15 M autocamtide-3 plus 200 mg/ml BSA and 50 Ci/ml
[- 32P]ATP in a final volume of 50 l either in the presence of 1 mM
EGTA (Ca 2/CaM-independent activity) or 1 mM CaCl2/2.4 M cal-
modulin (total activity). The reaction was incubated for 2 min at 30°C
and stopped by the addition of 10 l of ice-cold 20% TCA. Reactions
were centrifuged at 13,000 rpm for 2 min. Then 30 l of supernatant was
spotted on phosphocellulose discs and counted as described above.
Autonomous CaMKII activity is expressed as the percentage of total
activity that is Ca 2/CaM-independent.
Statistic analysis. The Western blot images on film were digitized by a
calibrated ImageScanner scanner and LabScan 3.0 software (Amersham
Pharmacia). The volumes of image spots were quantified by using the
ImageMaster 3 software (Amersham Pharmacia). Data were analyzed by
paired Student’s t test or by one-way ANOVA, followed by Newman–
Keuls multiple comparison tests that used GraphPad Prism (version 3.02;
GraphPad, San Diego, CA). Differences were considered significant at
p  0.05.
RESULTS
p39 interacts with -actinin-1 and CaMKII in a yeast
two-hybrid screen
Full-length p39 was used as bait in a yeast two-hybrid screen of a
human brain cDNA library. Two clones identified in this screen
were identical cDNA inserts encoding the full-length -subunit of
CaMKII (Fig. 1A). Both CaMKII cDNAs contained 120 bp of
5-untranslated region (UTR), the 1434 bp coding region, and a
1495 bp 3-UTR.
An additional cDNA clone identified in the screen represented
the C-terminal two-thirds of human -actinin-1 (also called non-
skeletal muscle -actinin). The -actinins are a family of closely
related proteins that are composed of three domains: an
N-terminal actin binding domain, a central region composed of
four spectrin-like repeats, and a C-terminal region containing two
Ca2-binding EF-hand motifs (Blanchard et al., 1989). Our
cDNA insert began at nucleotide 1087 (amino acid 363) and
extended for 1.8 kb. The encoded protein contains the last three
spectrin-like repeats and continues to the C-terminal end of the
protein (Fig. 1A).
-Actinin-1 and CaMKII bind distinct regions of p39
and p35
Seven cDNA clones of -actinin-1 also had been identified pre-
viously in a yeast two-hybrid screen by using full-length p35 as
bait and an embryonic mouse (E12.5) cDNA library (M. Nikolic
and L.-H. Tsai, unpublished observations). The -actinin-1 pro-
Figure 1. CaMKII and -actinin-1 interact with the Cdk5 activators p39 and p35, and with each
other, in a yeast two-hybrid system. A, A schematic of full-length CaMKII and -actinin-1
proteins is presented above a diagram of the protein encoded by the cDNA clones identified in the
screen. The numbers in parentheses indicate the number of copies of CaMKII and -actinin-1
cDNAs isolated in the screen. CaMKII contains an N-terminal kinase domain, a Ca 2/
calmodulin binding domain (CBD), and an association domain (AD). Both CaMKII cDNAs
identified in the screen contain the entire open reading frame (amino acid residues 1–478).
-Actinin-1 is composed of an N-terminal actin binding domain, a central region containing four
spectrin repeats (I–IV ), and a C terminus with two EF-hand motifs. The cDNA identified in the
screen encodes amino acid residues 363–892 of -actinin-1. B, cDNAs encoding full-length p39
(residues 1–369) and p35 (residues 1–307) or N- and C-terminal truncation mutants of p39 and p35
were tested for association with the CaMKII and -actinin-1 clones identified in the yeast
two-hybrid screen. Strength of an interaction is indicated by,,, or on the basis
of -galactosidase assays, whereas – denotes no interaction (see Materials and Methods). C,
Full-length or truncation mutants of CaMKII were tested for their ability to interact with
full-length p35 and p39 in a yeast two-hybrid -galactosidase assay. A schematic of the proteins
encoded by the CaMKII cDNAs is indicated. D, Full-length or truncation mutants of -actinin-1
were tested for their interaction with p35 and p39. A schematic representation of the proteins
encoded by -actinin-1 cDNAs is presented. The N terminus contains an actin binding domain
(ABD); the central region contains four spectrin-like repeats (SRI–IV ). The C terminus contains
a pair of EF-hand motifs (EF-H ) depicted by two vertical lines. E, Full-length or truncation mutants
of CaMKII were tested for their ability to interact with full-length -actinin-1 in a yeast two-hybrid assay. F, Full-length or truncation mutants of
-actinin-1 were tested for their ability to interact with full-length CaMKII in the yeast two-hybrid assay.
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tein encoded by all seven clones contained the last three spectrin-
like repeats and continued to the C-terminal end of the protein.
Moreover, p35 is 46% identical to p39, with 70% identity in the
C-terminal Cdk5 binding region (Tang et al., 1995). p35 could
bind to -actinin-1, and with greater affinity than p39, in the yeast
two-hybrid assay (Fig. 1B). p35 also could interact with
CaMKII in the yeast two-hybrid system, although the associa-
tion was weaker than with p39 (Fig. 1B).
The domains of p35 and p39 required for association with
full-length -actinin-1 and CaMKII were investigated in a yeast
two-hybrid system by using N- and C-terminal truncation mutants
of p35 and p39. The N terminus of p35 and p39 contains a
myristoylation signal and is thought to be critical for the mem-
brane localization of the two activators (Patrick et al., 1999;
Patzke and Tsai, 2002). The C-terminal two-thirds of p35 and p39
adopt a cyclin-box tertiary structure that is sufficient for binding
and activating Cdk5 (Qi et al., 1995; Tarricone et al., 2001). The
N-terminal regions of p39 and p35 could interact with -actinin-1
with equivalent or greater efficiency than the respective full-
length proteins, whereas the Cdk5 binding domains did not
display any association with -actinin-1 in the yeast two-hybrid
assay (Fig. 1B). This suggests that the N terminus of p35 and p39
is necessary and sufficient for association with -actinin-1. In
contrast, CaMKII could bind to the C terminus of p35 and p39
but did not interact with the N-terminal domains of these two
proteins (Fig. 1B). Thus CaMKII and -actinin-1 bind to dif-
ferent regions of both p35 and p39.
The N terminus of CaMKII is required for the
association with p35 and p39
All CaMKII subunits contain an N-terminal catalytic domain, a
central regulatory region, and a C-terminal association domain
(Fig. 1A) (Soderling et al., 2001). The regulatory region contains
an overlapping autoinhibitory domain and a Ca2/calmodulin
binding motif, whereas individual subunits interact via their as-
sociation domains to form a multimeric holoenzyme. The
N-terminal 316 residues of CaMKII, containing the catalytic
domain and the regulatory region, were necessary and sufficient
for binding to the Cdk5 activators (Fig. 1C).
p35 and p39 recognize two independent binding sites
on -actinin-1
The -actinin-1 clone identified in our yeast two-hybrid screen
contains the last three spectrin repeats and the EF-hand-
containing C-terminal domain. To narrow further the residues of
-actinin-1 that are required for association with the Cdk5 acti-
vators, we assessed the ability of truncation mutants of -actinin-1
to bind to full-length p39 and p35 in a yeast two-hybrid assay (Fig.
1D). The N-terminal actin binding domain of -actinin-1 did not
interact with p39 or p35 (Fig. 1D). A C-terminal truncation
mutant of -actinin-1, lacking the C-terminal EF-hand-
containing domain, demonstrated reduced binding to p35 and p39
compared with the full-length protein (Fig. 1D). This suggests
that, although the C-terminal region of -actinin-1 is not neces-
sary for association, residues in this domain may contribute to the
interaction with p35 and p39. In fact, the C-terminal region of
-actinin-1 alone was sufficient for association with p35 and p39
(Fig. 1D). A truncation mutant of -actinin-1 lacking both the
C-terminal domain and the N-terminal actin binding domain
could also interact with p39 and p35 (Fig. 1D). Larger N-terminal
deletions did not reduce binding further, and residues encoding
just the spectrin-like repeat IV domain were sufficient for asso-
ciation with both Cdk5 activators (Fig. 1D). Thus p35 and p39
can recognize at least two distinct regions of -actinin-1, one
contained in the spectrin-like repeat IV and the other in the
C-terminal region of the protein.
-Actinin-1 interacts with CaMKII
Walikonis and colleagues have shown that -actinin-4, another
member of the -actinin family, interacts with both the - and
-subunits of CaMKII at a site just downstream of its EF-hands,
between residues 806 and 871 (Walikonis et al., 2001).
-Actinin-1 and -actinin-4 are 88% identical and 97% similar in
this region (Honda et al., 1998). The authors suggest that
-actinin-1, which has been localized to the PSD (Walikonis et
al., 2000), also may be a physiologically relevant binding partner
of CaMKII. We therefore investigated this possibility directly. In
a yeast two-hybrid assay the full-length CaMKII and
-actinin-1 indeed did display a very strong interaction (Fig.
1E,F).
The N terminus of CaMKII, encompassing the kinase do-
main and the regulatory region, was sufficient for interaction with
-actinin-1, whereas the C-terminal association domain of
CaMKII did not display any binding (Fig. 1E). Thus, consistent
with the observations for -actinin-4 (Walikonis et al., 2001), the
N terminus of CaMKII is necessary and sufficient for associa-
tion with -actinin-1. Deletion of the C-terminal domain of
-actinin-1 completely abolished binding to CaMKII (Fig. 1F).
Further, the C-terminal domain of -actinin-1 alone could inter-
act with CaMKII with the same strength as the full-length
protein (Fig. 1F). As is the case for -actinin-4, the EF-hand-
containing C terminus of -actinin-1 is therefore necessary and
sufficient for binding to CaMKII (Walikonis et al., 2001).
CaMKII and -actinin-1 interact with p35/Cdk5 and
p39/Cdk5 complexes
We used GST pulldown assays to confirm the association of
-actinin-1 and CaMKII with p39 and p35 independently of the
yeast two-hybrid system. For these experiments we expressed
recombinant p39, p25, and Cdk5 as GST fusion proteins in
bacteria. Full-length p35 cannot be expressed as a GST fusion
protein because of severe degradation (Qi et al., 1995). There-
fore, GST-p25, the C-terminal Cdk5 binding and activating re-
gion of p35, was used in these assays. All GST fusion proteins
were used to pull down interacting proteins from adult rat brain
lysate, and associated proteins were identified by immunoblotting.
As expected, GST-p39 and GST-p25 both could bind to Cdk5 in
this assay (Fig. 2A). GST-p39 and GST-p25, but not GST alone,
also could precipitate CaMKII from adult rat brain lysate (Fig.
2A). GST-p29, containing the C terminus of p39, also can interact
with CaMKII (data not shown). These results are consistent
with the yeast two-hybrid data that indicate that the Cdk5-
activating domain of p35 and p39 is necessary and sufficient for
interaction with CaMKII. The specificity of the GST pulldowns
is demonstrated by showing that Lis1, a protein expressed at high
levels in the adult brain (Smith et al., 2000), does not interact with
the GST fusion proteins under these conditions.
Although full-length p39 could bind to -actinin-1 in our
pulldown assay, GST-p25 and GST alone did not interact with
-actinin-1 (Fig. 2A). GST-p29 also did not pull down -actinin-1
in these assays (data not shown), confirming that the N terminus
of p35 and p39 is necessary for interaction with -actinin-1.
GST-Cdk5 could pull down both CaMKII and -actinin-1, but
not Lis1, from brain lysate, presumably via its interaction with
p35 and p39 (Fig. 2A).
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The -actinin-1 clone obtained in the screen (residues 363–
892) was expressed as a recombinant GST fusion protein in
bacteria and was used to pull down interacting proteins from
adult rat brain lysate. In this assay GST--actinin-1, but not GST
alone, could interact with p39, p35, and Cdk5 (Fig. 2B). Immu-
noreactivity representative of p25 was not detected in the
-actinin-1 pulldowns, consistent with our previous GST pull-
down and yeast two-hybrid results that the N terminus of p35 and
p39 is necessary for association with -actinin-1 (Fig. 2B). To-
gether, the results from the GST pulldown assays suggest that
CaMKII and -actinin-1 can interact with the p35/Cdk5 and
p39/Cdk5 complexes in brain. Consistent with the yeast two-
hybrid interaction results, GST--actinin-1 also bound CaMKII
from adult rat brain lysate (Fig. 2B).
CaMKII, -actinin-1, and the Cdk5 activators interact
in vivo
To determine whether p39 and p35 interact with CaMKII and
-actinin-1 in vivo, we performed immunoprecipitations from
adult rat brain lysate by using antibodies against p35, p39, and
Cdk5, and we detected associated proteins via immunoblotting
(Fig. 2C). Both CaMKII and -actinin-1 were detected in p35,
p39, and Cdk5 immunoprecipitates, but not in control immuno-
precipitations with HA antibody (Fig. 2C). Under these condi-
tions Lis1 did not interact with p35, p39, or Cdk5, demonstrating
the specificity of the coimmunoprecipitations. Reverse immuno-
precipitations with the -actinin-1 antibody also precipitated p35,
p39, Cdk5, and CaMKII from adult rat brain lysate (Fig. 2D).
Together, these results suggest that CaMKII and -actinin-1
interact with each other and also form a complex with p35/Cdk5
and p39/Cdk5 in vivo. p39, p35, Cdk5, or -actinin-1 was not
detected in CaMKII immunoprecipitations (data not shown).
This could be attributable to the fact that CaMKII is a very
abundant protein in brain, and only a small portion of it interacts
with the Cdk5 activators and -actinin-1.
CaMKII, -actinin-1, and Cdk5 and its activators
colocalize in hippocampal neurons
CaMKII is a major component of excitatory synapses and is
enriched particularly at the PSD (Lisman et al., 2002). -Actinin
also has been localized at the PSD and in dendritic spines
(Wyszynski et al., 1997, 1998; Walikonis et al., 2000). We used
immunocytochemistry to determine whether Cdk5 and its acti-
vators colocalize with CaMKII and -actinin-1 at synaptic sites
in neurons (Fig. 3). Dissociated hippocampal neurons were main-
tained in culture for 3 weeks, during which time they develop
extensive processes and synaptic junctions and then were used for
immunocytochemistry.
In these hippocampal neurons the punctate staining of
CaMKII along processes was readily detectable (Fig. 3B,F).
Figure 2. CaMKII, -actinin-1, and Cdk5 and its activators interact in
adult rat brain. A, GST fusion proteins of p39 (GST-p39), p25 (GST-p25),
Cdk5 (GST-Cdk5), or GST alone were incubated with adult rat brain
lysate. Then 10% of the lysates used for the pulldowns (10% Input) and
the associated proteins were resolved by SDS-PAGE and detected by
immunoblotting with CaMKII, -actinin-1, Cdk5, and Lis1 antibodies,
as indicated on the right. B, GST alone and a GST fusion protein encoding
residues 363–892 of actinin-1 (GST--actinin-1) were incubated with
adult rat brain lysate, and the associated proteins were detected by
Western blotting with p39, p35, Cdk5, and CaMKII antibodies, as
indicated on the right. The p35 antibody recognizes both full-length p35
4
and the N-terminal truncation product termed p25, as indicated by the
arrows on the lef t. C, CaMKII and -actinin-1 coimmunoprecipitate
with Cdk5 and its activators. p35, p39, Cdk5, and HA antibodies (indi-
cated at the top of the lanes) were used for immunoprecipitations from
adult rat brain lysate. Then 5% of the lysate used for the immunoprecipi-
tation (5% Input) and the immunoprecipitated proteins were resolved by
SDS-PAGE and detected by immunoblotting with the antibodies indi-
cated on the right. D, -Actinin-1 or HA antibody was used for immuno-
precipitations from adult rat brain lysate. Then 10% of the proteins used
for the immunoprecipitations (10% Input) and the associated proteins
were resolved by SDS-PAGE and detected by immunoblotting with the
antibodies indicated on the right.
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Figure 3. CaMKII, -actinin-1, and Cdk5 and its activators colocalize in hippocampal neurons. Hippocampal neurons maintained in culture for
3 weeks were immunostained as described in Materials and Methods. A–L, Images were acquired by using a 60 oil-immersion objective. Scale
bar in A, 10 M (also applies to A–C, E–G, and I–K ). M–P, Image was acquired by using a 100 oil-immersion objective. Scale bar in M, 10 M
(also applies to N–P). A–D, Colocalization of Cdk5 and CaMKII. Hippocampal neurons were double stained for Cdk5 (A, green) and CaMKII
(B, red). C, The images shown in A and B are combined to reveal the colocalization of Cdk5 ( green) and CaMKII (red) in yellow. The boxed area
in C is presented in D at 3.5-fold magnification. E–H, Colocalization of p35 and CaMKII. Hippocampal neurons were double stained for p35
(E, green) and CaMKII (F, red). G, The images were merged to indicate colocalization between p35 ( green) and CaMKII (red) in yellow. The
boxed reg ion of the image in G is presented at 3.5-fold magnification in H. I–L, Colocalization of p35 and -actinin-1. Hippocampal neurons were
double stained for p35 (I, green) and -actinin-1 (J, red). L, The images were merged to indicate colocalization of p35 ( green) and -actinin-1 (red)
in yellow. The boxed reg ion of the image in K is presented at 3.5-fold magnification in L. M–P, Triple colocalization of Cdk5, CaMKII, and
-actinin-1. IgG- and IgM-specific secondary antibodies were used to triple-stain hippocampal neurons with Cdk5, CaMKII, and -actinin-1
antibodies (see Materials and Methods). M, Colocalization of Cdk5 ( green) and CaMKII (blue) in triple-stained neurons is revealed by the
blue-green color. N, Colocalization of Cdk5 ( green) and -actinin-1 (red) in triple-stained hippocampal neurons is visible as yellow. O,
Colocalization of CaMKII (blue) and -actinin-1 (red) in triple-stained hippocampal neurons is visible as pink. P, Triple colocalization of Cdk5
( green), -actinin-1 (red), and CaMKII (blue) in triple-stained neurons is visible as white.
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Discrete spots of Cdk5 immunostaining were visible along den-
drites (Fig. 3A), and an overlay of these images revealed punctate
colocalization of Cdk5 and CaMKII immunoreactivity along
dendrites (Fig. 3C,D). Like Cdk5, p35 immunoreactivity was
visible in neuronal shafts as well as in discrete puncta along
processes (Fig. 3E,I). Merged images of p35 and CaMKII
immunoreactivity revealed a punctate pattern of colocalization of
these proteins (Fig. 3G,H). p39 also colocalized with CaMKII in
these neurons (data not shown).
-Actinin-1 immunoreactivity was detected primarily in den-
dritic spines, with lower levels in the cytoplasm of neuronal
processes (Fig. 3J). In addition to staining along the length of
neurites, p35 also was present in very fine spiny protrusions, and
these p35 positive spines also were immunoreactive for
-actinin-1 (Fig. 3I–L). Similar colocalization with -actinin-1
also was observed for Cdk5 (Fig. 3N) and p39 in dendritic shafts
and spines (data not shown).
We used IgG- and IgM-specific secondary antibodies to deter-
mine whether triple colocalization of CaMKII, -actinin-1, and
Cdk5 was detectable in mature hippocampal neurons. High-
magnification images confirm the colocalization of Cdk5 with
CaMKII (Fig. 3M) and -actinin-1 (Fig. 3N). Overlap of
CaMKII and -actinin-1 immunoreactivity indicates that these
two proteins also colocalize in discrete spots along dendrites (Fig.
3O). Triple labeling indicates that a subset of -actinin-1/
CaMKII sites also contains Cdk5 immunostaining, as indicated
by the white color in the merged images (Fig. 3P). Triple colo-
calization of CaMKII and -actinin-1 with either p35 or p39
also was detectable in these neurons (data not shown). This
suggests that CaMKII, -actinin-1, and Cdk5 along with its
activators all can colocalize in mature hippocampal neurons,
supporting the possibility that they can exist in a complex. The
partial overlap between Cdk5/-actinin-1 and Cdk5/CaMKII
coimmunostaining suggests that, although a complex of Cdk5,
CaMKII, and -actinin-1 may exist at synapses, exclusive com-
plexes of Cdk5/CaMKII, Cdk5/-actinin-1, and CaMKII/-
actinin-1 are also probably present.
Ca2 stimulates the association of p35 with CaMKII
and -actinin-1
Changes in intracellular Ca2 levels have been shown to regulate
the binding and signaling properties of both -actinin-1 and
CaMKII (Blanchard et al., 1989; Krupp et al., 1999; Soderling et
al., 2001; Lisman et al., 2002). To determine whether Ca2 affects
the association of CaMKII or -actinin-1 with the Cdk5 acti-
vators, we tested the ability of p35, p39, or -actinin-1 antibodies
to coimmunoprecipitate associated proteins from adult rat brain
lysate in the presence of increasing Ca2 concentrations (Fig. 4).
In the absence of exogenously added Ca2, we could detect
coimmunoprecipitation of both -actinin-1 and CaMKII with
p35 (Figs. 2C, 4A). The addition of 10 M Ca2 to brain lysates
stimulated a detectable increase in the coimmunoprecipitation of
both -actinin-1 and CaMKII with p35 (Fig. 4A). The addition
of 10–50 M Ca 2 to brain lysates resulted in a twofold increase
in the coimmunoprecipitation of -actinin-1 with p35 and a three-
fold to fourfold increase in the association of CaMKII with p35.
The -actinin-1 and CaMKII that coimmunoprecipitated with
p35 at high Ca2 concentrations was not attributable to nonspe-
cific precipitation of protein aggregates because no protein was
detected in the non-IgG controls (Fig. 4A,C). The addition of 1
mM EDTA reduced the coimmunoprecipitation of -actinin-1
and CaMKII with p35 (Fig. 4A). The addition of calcium to
brain lysates similarly induced coimmunoprecipitation of
actinin-1 and CaMKII with p39, whereas the addition of EGTA
inhibited the associations (Fig. 4B). In contrast, the coimmuno-
precipitation of Cdk5 with p35 or p39 was not affected by chang-
ing calcium, EDTA, or EGTA concentration in brain lysates (Fig.
4A,B).
Reverse immunoprecipitations with -actinin-1 antibody also
revealed the increased coimmunoprecipitation of p35 with
-actinin-1 after the elevation of Ca2 concentrations in brain
lysates (Fig. 4C). Interestingly, increasing the Ca2 concentration
in brain lysates also enhanced the coimmunoprecipitation of
CaMKII with -actinin-1, with a twofold increase in the coim-
munoprecipitation of these proteins after the addition of 10 M
Ca2 (Fig. 4C). The addition of MgCl2 to brain lysates did not
increase the coimmunoprecipitation of CaMKII or -actinin-1
with p35 (Fig. 4D), indicating that this effect is specific for Ca2
and is not the result of increasing concentrations of general
divalent cations. Our results suggest that Ca2 can stimulate the
association of CaMKII and -actinin-1 with p35 as well as with
each other.
Glutamate treatment of neurons can regulate the
association of p35 with CaMKII
The stimulation of glutamate receptors in neurons can lead to
increases in cytosolic Ca2 (Nakanishi et al., 1998). We therefore
investigated whether the treatment of neurons with glutamate
could modulate the association of the Cdk5 activators with
CaMKII and -actinin-1. Dissociated hippocampal neurons
were maintained in culture for 2 weeks and then were treated
with 100 M glutamate/10 M glycine in a Mg2-free buffer for 5
min. After treatment, p35 and -actinin-1 were immunoprecipi-
tated from lysates of these neurons, and the associated proteins
were detected by Western blotting (Fig. 5A,B). Both CaMKII
and -actinin-1 coimmunoprecipitated with p35 under basal con-
ditions, and the treatment of hippocampal neurons with gluta-
mate induced a significant increase in the amount of CaMKII
that coimmunoprecipitated with p35 (Fig. 5A). Surprisingly, no
increase in the coimmunoprecipitation of -actinin-1 and p35 was
detected under the same treatment conditions (Fig. 5A,B). Glu-
tamate treatment also did not affect CaMKII coimmunoprecipi-
tation with -actinin-1 significantly (Fig. 5B). In fact, a slight
decrease in association between CaMKII and -actinin-1 was
seen in some experiments, but this effect did not prove to be
significant in repeated experiments (Fig. 5B).
We also wanted to determine whether glutamate treatment
could result in altered Cdk5 kinase activity. Toward this end we
used the p35 antibody to immunoprecipitate the p35/Cdk5 com-
plex from lysates of control and glutamate-stimulated hippocam-
pal neurons. We detected no change in Cdk5 kinase activity after
comparing the Cdk5 kinase activity of these precipitates in an in
vitro kinase assay by using Histone H1 as a substrate (Fig. 5C).
CaMKII activation is required for the glutamate-
dependent increase in the association of p35
with CaMKII
Our data suggest that the stimulation of glutamate receptors in
neurons can enhance the association of CaMKII with the Cdk5
activators. To determine whether Ca2 influx was required for
this effect, we treated hippocampal slices with 100 M gluta-
mate/10 M glycine for 5 min in the presence or absence of 5 mM
EDTA. As in the dissociated hippocampal neurons, the treatment
of hippocampal slices with glutamate enhanced the coimmuno-
precipitation of CaMKII with p35 (Fig. 6A). Pretreatment of
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the slices with 5 mM EDTA to reduce extracellular free calcium
blocked the glutamate effect, suggesting that calcium influx is
critical (Fig. 6A). The treatment of hippocampal slices with
glutamate also resulted in an increase in the coimmunoprecipita-
tion of CaMKII with p39, which could be abolished by pretreat-
ment with EGTA (Fig. 6B).
A relationship between CaMKII activation and its association
with the Cdk5 activators was investigated by the treatment of
hippocampal slices with kinase inhibitors. Pretreatment with the
CaMKII inhibitors KN62 and KN93 reduced the glutamate-
mediated increase in the association of p35 with CaMKII (Fig.
6C). The structurally similar but inactive analog of KN93 (KN92)
and the PKA inhibitor H-89 had no effects. None of these treat-
ments altered the association between p35 and Cdk5, also mea-
sured by coimmunoprecipitation. Consistent with previous re-
ports (Fukunaga et al., 1992; Tan and Chen, 1997), glutamate
treatment of the slices stimulated CaMKII autonomous activity,
which was abolished by the pretreatment of slices with KN62 and
KN93, but not by KN92 or H-89 (Fig. 6C). This suggests that the
glutamate-mediated activation of CaMKII may regulate the for-
mation or maintenance of the p35/CaMKII complex. Both
KN62 and KN93, although commonly used as CaMKII inhibi-
tors, have been reported to inhibit other members of the Ca2/
CaM-dependent family, and we cannot rule out that the inhibition
of other family members in our assay may contribute to the
regulation of the CaMKII/p35 complex.
Activation of NMDA receptor enhances the association
of p35 and CaMKII
To identify the specific neurotransmitter receptors involved in the
glutamate-mediated stimulation of p35/CaMKII coimmunopre-
cipitation, we treated hippocampal slices with glutamate in the
presence of glutamate receptor antagonists (Fig. 7). Ionotropic
glutamate receptor antagonists were effective in reducing the
glutamate-stimulated increase in p35/CaMKII association. A
combination of antagonists, used to block all glutamate receptors,
completely abolished the glutamate effect, but the NMDA recep-
tor antagonist MK801 alone reduced the association virtually to
basal levels (Fig. 7). The non-NMDA receptor antagonist CNQX
Figure 4. Ca 2-dependent association of CaMKII, -actinin-1, and
the Cdk5 activators. A, Ca 2 enhances the coimmunoprecipitation of
CaMKII and -actinin-1 with p35. EDTA (1 mM) or CaCl2 was added
to adult rat brain lysate to a final concentration indicated above the lanes
4
(0–5 mM). p35 antibody ( p35 IP) or no antibody (no Ab) was used for
immunoprecipitations from these lysates, and the immunoprecipitated
samples were resolved by SDS-PAGE. The amounts of associated
-actinin-1 (top), CaMKII (middle), and Cdk5 (bottom) were analyzed
by Western blots. Then 5% of the lysates used for the immunoprecipita-
tions (Lysate) was analyzed by Western blotting for the levels of p35,
-actinin-1, CaMKII, and Cdk5. B, Ca 2 enhances the coimmunopre-
cipitation of CaMKII and -actinin-1 with p39. EGTA (1 mM) or CaCl2
was added to adult rat brain lysate to a final concentration indicated above
the lanes. p39 antibody ( p39 IP) was used for immunoprecipitations from
these lysates; the amounts of associated -actinin-1 (top), CaMKII
(middle), and Cdk5 (bottom) were analyzed by Western blots. C, Ca 2
enhances the coimmunoprecipitation of p35 and CaMKII with
-actinin-1. The same samples described in A were used for immunopre-
cipitations with the -actinin-1 antibody (-actinin-1 IP) or no antibody
(no Ab). The amounts of associated p35 (top), CaMKII (middle), and
-actinin-1 (bottom) were analyzed by Western blots. D, Magnesium does
not enhance the coimmunoprecipitation of CaMKII and -actinin-1
with p35. CaCl2 (Ca
2) or MgCl2 (Mg
2) was added to adult rat brain
lysate to a final concentration indicated above the lanes. p35 antibody was
used for immunoprecipitations from these lysates. Then 10% of the
lysates used for the immunoprecipitations (10% Input) and the immuno-
precipitated samples ( p35 IP) were resolved by SDS-PAGE. The amounts
of associated -actinin-1 (top), CaMKII (middle), and Cdk5 (bottom)
were analyzed by Western blots.
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also caused a smaller but statistically significant reduction,
whereas treatment with the mGluR antagonist AIDA had no
effect (Fig. 7). These results suggest that the CaMKII/p35
association triggered by glutamate treatment occurs predomi-
nantly via NMDA receptor signaling.
In further support, the treatment of hippocampal slices with
NMDA dramatically increased the association of CaMKII with
p35, mimicking the effect of glutamate (Fig. 7). The NMDA-
mediated association could be abolished by pretreatment with the
receptor antagonist MK801 or with the CaMKII inhibitor KN62.
Stimulation with AMPA also enhanced the association between
p35 and CaMKII, but not as efficiently as with NMDA. To-
gether, our data suggest that the activation of CaMKII by
NMDA receptor favors the association of CaMKII with p35.
DISCUSSION
Several presynaptic and postsynaptic proteins have been identi-
fied as Cdk5 substrates, and a role for Cdk5 in synaptogenesis
and synaptic transmission is beginning to emerge (Dhavan and
Tsai, 2001). In this study we report that CaMKII and
-actinin-1 interact with Cdk5 via its activators p35 and p39.
CaMKII and -actinin-1 bind distinct domains of the Cdk5
activators and can also interact with each other. Triple colocal-
ization of CaMKII and -actinin-1 with Cdk5 and its activators
is detected in neurons, suggesting that these proteins can exist
together in a complex. Ca2 augments the association of
CaMKII and -actinin-1 with p35 and p39 and also enhances
their interaction with each other. Stimulation of glutamate recep-
tors also could increase the association of the Cdk5 activators
with CaMKII, and this effect is mediated primarily by the
NMDA receptors. Together, these results suggest that Cdk5, via
its activators, forms a complex with CaMKII and -actinin-1
that may be modulated by synaptic activity.
Interaction of Cdk5 and CaMKII with -actinin-1
The -actinin family members are actin cross-linking proteins
that bind and tether cell surface receptors, ion channels, and
Figure 5. Glutamate treatment of dissociated hippocampal neurons en-
hances the association of CaMKII and p35. A, Dissociated hippocampal
4
neurons in culture for 2 weeks were treated (Glu/Gly) with buffer () or
100 M glutamate/10 M glycine () for 5 min. Crude synaptosome
fractions prepared from these neurons were used for the immunoprecipi-
tation of p35. Then 10% of the proteins used for the immunoprecipita-
tions (10% Input) and the p35-associated proteins ( p35 IP) were resolved
by SDS-PAGE. The amounts of CaMKII (top), -actinin-1 (middle),
and Cdk5 (bottom) were analyzed by immunoblotting. Quantitative anal-
ysis from three independent experiments is presented in the histogram.
The amount of CaMKII, -actinin-1, and Cdk5 immunoprecipitated
with p35 is presented as a percentage of the values that were measured in
control treatments and is the mean  SEM of three independent exper-
iments. *Statistically different ( p 0.05) from control values by Student’s
t test. B, The same lysates described in A were used for immunoprecipi-
tation with -actinin-1 antibody. Then 10% of the proteins used for the
immunoprecipitations (10% Input) and the -actinin-1-associated pro-
teins (-actinin-1 IP) were resolved by SDS-PAGE; the amounts of p35
(top) and CaMKII (bottom) were analyzed by immunoblotting. Quan-
titative analysis from three independent experiments is presented in the
histogram. The amount of CaMKII and p35 immunoprecipitated with
-actinin-1 is presented as a percentage of the values that were measured
in control treatments and is the mean  SEM of three independent
experiments. C, Cdk5 kinase activity is unaltered by glutamate treatment
of hippocampal neurons. Dissociated hippocampal neurons were treated
with either buffer (Control ) or 100 M glutamate/10 M glycine (Glu/Gly),
as described in A. The Cdk5/p35 complex was immunoprecipitated with
p35 antibody, and Cdk5 kinase activity was measured in an in vitro kinase
assay toward Histone H1. The Cdk5 kinase activity is presented as a
percentage of the values that were measured from control-treated neurons
and is the mean  SEM from three independent experiments.
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adhesion complexes to the actin cytoskeleton (Blanchard et al.,
1989; Otey et al., 1990; Knudsen et al., 1995; Wyszynski et al.,
1997; Cukovic et al., 2001). Both -actinin-1 and -actinin-2 are
present in the PSD and in dendritic spines (Wyszynski et al., 1997,
1998; Walikonis et al., 2000). -Actinin-2 binds directly to both
the NR1 and NR2B NMDA receptor subunits (Wyszynski et al.,
1997) and is thought to modulate receptor function by anchoring
the receptor to the actin cytoskeleton. This is supported by
studies showing that depolarization of the actin cytoskeleton is
associated with the depression of NMDA receptor-mediated
transmission (Rosenmund and Westbrook, 1993; Paoletti and
Ascher, 1994). Disruption of the actin cytoskeleton also results in
a complete loss of CaMKII from the PSD and -actinin from
spines (Allison et al., 1998, 2000). The association of CaMKII
and Cdk5 with -actinin-1 may serve to anchor the kinases to the
subsynaptic cytoskeleton and perhaps modulate the association of
the two kinases to the NMDA receptor and other substrates at
the PSD.
Ca 2 was found to enhance the association of CaMKII and
-actinin-1 with the Cdk5 activators. We observed a significant
increase in association of p35 and p39 with CaMKII and
-actinin-1 after the addition of 10 M calcium (Fig. 4). Measure-
Figure 6. Ca 2 influx and CaMKII ac-
tivity are required for the glutamate-
mediated enhanced association of the
Cdk5 activators and CaMKII. *Statis-
tically different ( p  0.05) from control
treatments; **statistically different ( p 
0.05) from Glu/Gly treatment by one-
way ANOVA. A, Hippocampal slices
were treated with either buffer or 100
M glutamate/10 M glycine (Glu/Gly)
in the absence or presence of 5 mM
EDTA for 5 min. Crude synaptosome
fractions prepared from these neurons
were used for the immunoprecipitation
of p35. The amounts of CaMKII (top)
and Cdk5 (bottom) associated with p35
were analyzed by immunoblotting.
Quantitative analysis from three inde-
pendent experiments is presented in the
histogram. The amount of CaMKII
immunoprecipitated with p35 is pre-
sented as a percentage of the values that
were measured in control treatments
and is the mean  SEM of three inde-
pendent experiments. B, Hippocampal
slices were treated with 100 M gluta-
mate/10 M glycine (Glu/Gly) in the
absence or presence of 5 mM EGTA for
5 min. The lysates were used for the
immunoprecipitation of p39, and the
amounts of CaMKII (top) and Cdk5
(bottom) associated with p39 were ana-
lyzed by immunoblotting. Quantitative
analysis from three independent exper-
iments is presented in the histogram. C,
Hippocampal slices were treated with
either buffer or 100 M glutamate/10 M
glycine (Glu/Gly) in the presence or ab-
sence of 10 M each KN62, KN93, and
KN92 or 0.5 M H-89 for 5 min. Crude
synaptosome fractions prepared from
these neurons were used for the immu-
noprecipitation of p35. The amounts of
CaMKII (top) and Cdk5 (bottom) as-
sociated with p35 were analyzed by im-
munoblotting. Quantitative analysis
from three independent experiments is
presented in the middle histogram. The
amount of CaMKII immunoprecipi-
tated with p35 is presented as a percent-
age of the values that were measured in
control treatments and is the mean 
SEM of three independent experi-
ments. In the bottom histogram crude
synaptosome fractions prepared from
the treated slices described above were
assayed for total and Ca 2/CaM-
independent CaMKII kinase activity (see Materials and Methods). Autonomous CaMKII activity is defined as the Ca 2/CaM-independent activity
expressed as a percentage of the total CaMKII activity. The autonomous CaMKII activity in slices is expressed as a percentage of the autonomous
CaMKII activity in control slices and is the mean  SEM from three independent experiments.
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ments of NMDA receptor-dependent calcium influxes have dem-
onstrated increases in calcium concentration in distal CA1 spines
to as much as 20–40 M in organotypic slice culture and acute
slices, similar to the system we used (Petrozzino et al., 1995;
Sabatini et al., 2001). The threefold to fourfold increase in asso-
ciation between the Cdk5 activators and CaMKII after the
addition of 10–50 M calcium is very comparable with the in-
crease in association observed after the stimulation of NMDA
receptors in hippocampal slices or neuronal cultures. However,
the physiological relevance of the 20- to 30-fold increase in the
association of these proteins at calcium concentrations higher
than 300 M is unclear.
-Actinin-1 contains a functional EF-hand motif that can bind
Ca 2, and the association with Ca2 inhibits its ability to bind
and cross-link actin. Ca2 also regulates the association of
-actinin with the NMDA receptor (Wyszynski et al., 1997;
Zhang et al., 1998; Krupp et al., 1999). A Ca2-dependent
association with -actinin might serve to regulate Cdk5 and
CaMKII interactions with the actin cytoskeleton as well as the
NMDA receptor subunits. Although increasing the concentration
of Ca2 in brain lysate enhanced the association of -actinin-1
with CaMKII and Cdk5, the glutamate treatment of hippocam-
pal neurons did not produce a similar increase in complex for-
mation. Further investigation is required to determine more
closely whether physiological or pathological changes in intracel-
lular Ca2 levels can regulate the association of -actinin with
the Cdk5 activators or CaMKII.
The association of -actinin-1 with the Cdk5 activators may be
regulated by neurotoxicity. Exposure to neurotoxic insults in-
duces a calpain-mediated cleavage of p35 and p39 to generate p25
and p29, respectively (Lee et al., 2000; Patzke and Tsai, 2002).
Cleavage of p35 and p39 results in a longer half-life than the
full-length activator and a loss of the N-terminal myristoylation
signal (Patrick et al., 1999; Patzke and Tsai, 2002). Generation of
p25 or p29, therefore, results in prolonged activation and mislo-
calization of Cdk5, causing cytoskeletal disruptions and cell
death. Indeed, the accumulation of p25 has been implicated in the
pathogenesis of neurodegenerative diseases such as Alzheimer’s
disease and amyotrophic lateral sclerosis (Dhavan and Tsai,
2001). We have demonstrated that -actinin-1 cannot interact
with p25 or p29. Exposure to neurotoxic insults therefore may
disrupt the association of the Cdk5 activators with -actinin-1,
contributing to the deregulation of Cdk5 activity and subcellular
distribution.
Our interaction data and triple colocalization of CaMKII and
-actinin-1 with Cdk5 and its activators suggest that these pro-
teins form a complex together. This is formally possible because
CaMKII and -actinin-1 bind distinct sites on p35 and p39.
Further, whereas CaMKII and p35/p39 bind to the C terminus
of -actinin-1, p35 and p39 also can bind independently on at
least one additional site in the spectrin-repeat region of
-actinin-1. It is therefore also possible that the Cdk5 activators
and CaMKII can bind to -actinin-1 simultaneously. -Actinin-4
recently was found to associate with CaMKII in a ternary com-
plex that also contained the PSD protein Densin-180 (Walikonis
et al., 2001). The Cdk5 activators may interact with Densin-180
via their association with either -actinin-1 and/or CaMKII.
Interaction of Cdk5 and CaMKII
CaMKII interacts with the C-terminal Cdk5 binding region of
p35 and p39. Our coimmunoprecipitation data suggest that
CaMKII associates with Cdk5 in vivo, presumably via its inter-
action with the Cdk5 activators. Several p35 binding proteins
have been identified, including -catenin, neurofilament subunits,
and tau, which can bind to the C terminus of p35 simultaneously
with Cdk5 (Patrick et al., 1999; Kesavapany et al., 2001). Further,
Figure 7. Activation of the NMDA receptor enhances the association of
CaMKII and p35. Hippocampal slices were treated with either buffer or
100 M glutamate/10 M glycine in the absence (Glu) or presence of 10
M MK801 (Glu/MK801), 100 M CNQX (Glu/CNQX ), 100 M AIDA
(Glu/AIDA), and 10 M MK801 plus 100 M CNQX plus 100 M AIDA
(Glu/MK801CNQXAIDA) for 5 min. Hippocampal slices also were
treated with either 100 M NMDA in the absence (NMDA) or presence
of 10 M MK801 (NMDA/MK801) or 10 M KN62 (NMDA/KN62) or 100
M AMPA in the absence (AMPA) or presence of 100 M CNQX
(AMPA/CNQX ) or 10 M KN62 (AMPA/KN62) for 5 min. Crude synap-
tosome fractions prepared from these neurons were used for the immu-
noprecipitation of p35. The amounts of CaMKII (top) and Cdk5 (bot-
tom) associated with p35 were analyzed by immunoblotting. Quantitative
analysis from three independent experiments is presented in the histo-
gram. The amount of CaMKII immunoprecipitated with p35 is pre-
sented as a percentage of the values that were measured in control
treatments and is the mean  SEM of three independent experiments.
aStatistically different ( p  0.05) from control treatment; bstatistically
different ( p 0.05) from Glu treatment; cstatistically different ( p 0.05)
from NMDA treatment; dstatistically different ( p  0.05) from AMPA
treatment by one-way ANOVA.
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CaMKII colocalizes with Cdk5 and its activators in mature
hippocampal neurons, supporting our interaction data that
CaMKII can form a complex with p35/Cdk5 and p39/Cdk5.
Enhanced association between p35 and CaMKII was observed
after an increase in the calcium concentration in brain lysates and
with the glutamate treatment of hippocampal cultures and slices.
We have reported previously that glutamate-mediated neurotoxic
stress and calcium influx induce the calpain-dependent cleavage
of p35 and p39 (Lee et al., 2000; Patzke and Tsai, 2002). The
experiments in this study were, however, not performed under
comparable conditions to activate calpain, and we have not ob-
served a significant increase in the cleavage of p35 or p39 in our
studies.
The effects of glutamate on neurons are mediated by several
different types of receptors, all of which can lead to increases in
cytosolic calcium (Nakanishi et al., 1998). Our pharmacologic
evidence, however, indicates that the increased association be-
tween p35 and CaMKII is dependent mainly on NMDA receptor
activity, because NMDA treatment mimicked the effect of gluta-
mate and MK801 reduced the increases that were stimulated by
glutamate or NMDA virtually to basal levels. Furthermore, be-
cause the reduction in free calcium ions or the inhibition of
CaMKII also effectively blocks the glutamate and NMDA effects,
our data suggest that calcium entry via NMDA receptors acti-
vates CaMKII and triggers its association with the Cdk5 activa-
tors in synaptic sites.
In contrast, the inhibition of metabotropic glutamate receptors
did not change the glutamate-mediated increases in p35/CaMKII
complex association, although these receptors can trigger calcium
release from internal stores (Hermans and Challiss, 2001), acti-
vate Cdk5 (Liu et al., 2001), and interact directly with calmodulin
(Minakami et al., 1997). A small component of the glutamate
effect appeared to be mediated by AMPA receptor activity, and,
although a direct AMPA receptor mechanism cannot be ruled
out, it is possible that the modest changes observed with the
AMPA agonists and antagonists are attributable to secondary
effects of depolarization on NMDA receptor activation. Thus our
results, together with other reports that NMDA receptor and
CaMKII activities are coupled closely (Bayer and Schulman,
2001), indicate that the calcium-dependent association of p35 and
CaMKII stimulated by glutamate is mediated predominantly by
NMDA receptor activity.
Glutamate stimulation of hippocampal neurons, although re-
sulting in a CaMKII activity-dependent increase in the associa-
tion of p35 with CaMKII, did not result in changes in Cdk5
kinase activity. It is possible that the Cdk5 association with
CaMKII, rather than regulating Cdk5 activity, modulates its
synaptic localization and association with synaptic proteins.
CaMKII is reported to translocate from dendritic shafts into the
PSD after NMDA receptor stimulation (Strack et al., 1997; Shen
and Meyer, 1999). The autophosphorylation-dependent and
-independent association of CaMKII with the NMDA receptor
subunits is thought to play a role in its translocation as well as in
anchoring CaMKII at the PSD (Bayer et al., 2001). At the PSD,
CaMKII can phosphorylate the NR2A and NR2B receptor sub-
units (Omkumar et al., 1996; Strack et al., 2000). Phosphorylation
of the GluR1 subunit of the AMPA receptor by CaMKII en-
hances channel conductance, which might contribute to long-term
potentiation (Derkach et al., 1999). Cdk5 also has been shown to
phosphorylate the NR2A subunit of the NMDA receptor, and the
inhibition of Cdk5 activity reduces channel conductance (Li et
al., 2001). The increased association of p35 with CaMKII after
neuronal activity might facilitate the localization and association
of Cdk5 in the vicinity of the NMDA receptor and its other
putative substrates at the PSD.
The multiple mechanisms that modulate synaptic strength have
been shown to involve cross talk among complex signal transduc-
tion pathways of the Src family tyrosine kinases, protein kinase A,
protein kinase C, mitogen-activated protein kinase, and CaMKII
(Soderling and Derkach, 2000; Grant and O’Dell, 2001; Soderling
et al., 2001). Functional consequences of the association of
CaMKII and Cdk5, as well as their shared regulatory and target
interactions with proteins such as -actinin-1 and the NMDA
receptor, may elucidate novel mechanisms that are important in
synaptic transmission and plasticity.
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